Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Editas Medicine, Inc. (EDIT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 702 shares
@ $8.5935, valued at
$6k
|
|
| 08/10/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 141 shares
@ $8.39, valued at
$1.2k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2023 |
4
| O'Neill Gilmore Neil (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 6,486 shares
@ $9.5032, valued at
$61.6k
|
|
| 06/07/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 105 shares
@ $9.503, valued at
$997.8 |
|
| 05/18/2023 |
4
| Lucera Erick (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 77,900 shares
@ $0
Granted 155,800 options to buy
@ $9.61, valued at
$1.5M
|
|
| 05/15/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 949 shares
@ $9.872, valued at
$9.4k
|
|
| 05/15/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 668 shares
@ $9.872, valued at
$6.6k
|
|
| 05/11/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 135 shares
@ $9.51, valued at
$1.3k
|
|
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 31,500 shares
@ $0
Sold 184 shares
@ $8.89, valued at
$1.6k
Granted 94,500 options to buy
@ $8.72, valued at
$824k
|
|
| 03/06/2023 |
4
| Mei Baisong (SVP, CHIEF MEDICAL OFFICER) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 54,000 options to buy
@ $8.72, valued at
$470.9k
|
|
| 03/06/2023 |
4
| O'Neill Gilmore Neil (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 150,000 options to buy
@ $8.72, valued at
$1.3M
|
|
| 03/06/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 16,700 shares
@ $0
Sold 101 shares
@ $8.89, valued at
$897.9
Granted 50,000 options to buy
@ $8.72, valued at
$436k
|
|
| 02/09/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 346 shares
@ $11.1, valued at
$3.8k
|
|
| 01/12/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,752 shares
@ $8.1601, valued at
$14.3k
|
|
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 192 shares
@ $15.01, valued at
$2.9k
|
|
| 09/08/2022 |
4
| Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 101 shares
@ $15.01, valued at
$1.5k
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Mei Baisong (SVP, CHIEF MEDICAL OFFICER) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 58,372 shares
@ $0
Granted 171,602 options to buy
@ $14.99, valued at
$2.6M
|
|
| 06/16/2022 |
4
| Shearman Mark S (EVP, CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 5,145 shares
@ $10.0573, valued at
$51.7k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Reeve Emma (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.31, valued at
$307.8k
|
|
| 06/13/2022 |
4
| Scadden David (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.31, valued at
$307.8k
|
|
| 06/13/2022 |
4
| Hopfield Jessica (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.31, valued at
$307.8k
|
|
| 06/13/2022 |
4
| Chatterjee Meeta (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.31, valued at
$307.8k
|
|
| 06/13/2022 |
4
| Hirsch Andrew (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.31, valued at
$307.8k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,527 shares
@ $11.5369, valued at
$17.6k
|
|
|
|
|